AUA 2026
Abstracts Sponsored by Bayer
May 15-18, 2026
Agenda of oral and poster presentations at the 2026 American Urological Association (AUA) Annual Meeting
Please see below to download a PDF for each presentation and view a video (where applicable). Access for each publication will be available after the congress presentation.
Please select a compound to navigate to all related publications.
DAROLUTAMIDE
Real-world darolutamide safety and effectiveness in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) with comorbidities and concomitant medications: Post hoc analyses at DAROL interim analysis 4 (IA4)
Date/Time: Monday, May 18 | 2026 7:00 AM – 9:00 AM
Session: Prostate Cancer: Advanced (including Drug Therapy) III
Type: Interactive Poster Session
Presenting Author: Murilo De Almeida Luz
IP73-13
Practice-changing, Paradigm-shifting Clinical Trials in Urology: Darolutamide plus androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC): ARASEC – US prospective, open-label phase 2 study with an external control
Date/Time: Friday, May 15 | 2026 11:00 AM – 11:10 AM
Session: P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology
Type: Plenary
Presenting Author: Rana McKay
The compendium provided by Bayer is a compilation of Bayer sponsored presentations. Copies of presentations obtained from this compendium are for personal use only and may not be reproduced or distributed without permission from The American Urological Association (AUA) and from the authors. The compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities
Reused with permission. © 2026 The American Urological Association (AUA). All rights reserved.
For any questions, please contact Medical Information at 1-888-84-BAYER (1-888-842-2937), or visit go.bayer.com/vPIR
© 2026 Bayer. All rights reserved. Bayer and the Bayer Cross are registered trademarks of Bayer. 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981 USA. 4/26
MA-M_DAR-US-0417-1
MA-M_DAR-US-0418-1